Biochemistry, Genetics and Molecular Biology
Genomics
98%
Pan-cancer
56%
Gene Expression
55%
P53
50%
Whole Genome Sequencing
38%
Genetics
37%
Gene Mutation
36%
Carcinogenesis
35%
Epigenetics
33%
Myeloid
32%
Immunity
32%
Transcriptome
29%
Long Non-Coding RNA
29%
Stem Cell
24%
Immune Checkpoints
24%
Somatic Mutation
24%
Promoter Region
23%
Gene Expression Profiling
21%
Single-Nucleotide Polymorphism
20%
Cancer Cell
20%
Allele
19%
Next Generation Sequencing
18%
Wart Virus
18%
Phosphotransferase
17%
Kinase
17%
DNA Methylation
17%
RNA
15%
Exome Sequencing
14%
Enhancer Region
14%
Histone
14%
Mouse Model
14%
Homeostasis
14%
RNA Sequence
13%
Prevalence
13%
APOBEC
13%
Alternative Splicing
13%
Methionine
13%
MicroRNA
13%
TFE3
12%
Human Papillomavirus Type 16
12%
Immunocompetent Cell
12%
Programmed Cell Death
12%
Tissue Regeneration
11%
IKZF1
11%
Tamsulosin
11%
SMARCB1
11%
Transcription Factor
11%
NPM1
11%
RNA Sequencing
10%
Spectrin
10%
Keyphrases
Whole Genome
94%
Pan-cancer Analysis
84%
Tumor
52%
Human Cancer
41%
Molecular Characterization
36%
In Cancer
26%
Genetic Modification
22%
Structural Variants
19%
Whole Genome Sequencing
18%
Clear Cell Renal Cell Carcinoma (ccRCC)
16%
RNA Sequencing (RNA-seq)
15%
Acute Lymphoblastic Leukemia
15%
Triple-negative Breast Cancer
14%
Tumor Protein p53 (TP53)
14%
Mutant p53
14%
Trp53
13%
Muscle-invasive Bladder Cancer
13%
Upper Tract Urothelial Carcinoma
13%
Renal Medullary Carcinoma
13%
Mutational Processes
13%
Mitochondrial DNA
13%
Copy number Variation
12%
Tumor Subtype
12%
High-risk Human Papillomavirus (HR-HPV)
12%
Mouse Model
12%
Hepatocellular Carcinoma
12%
Transcriptome
11%
Cancer Genome Atlas
11%
Genomic Analysis
11%
Gene Expression
10%
Cancer Types
10%
Genetic mutation
10%
Non-coding
10%
Breast Cancer Cells
9%
Missense mutation
9%
Tumorigenesis
9%
Tumor Development
9%
Osteosarcoma
9%
Genome Rearrangement
9%
Overexpression
9%
Chromatin Folding
9%
Sarcomatoid
9%
Cancer Metastasis
9%
Alternative Splicing
9%
Gain-of-function
9%
Translocation Renal Cell Carcinoma
9%
RNA Alteration
9%
Menin Inhibitors
9%
Liver Tumorigenesis
9%
Cancer Initiation
9%
Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
78%
Clear Cell Renal Cell Carcinoma
41%
Cancer
30%
Carcinogenesis
25%
Protein P53
20%
Acute Lymphoblastic Leukemia
19%
Metastatic Carcinoma
17%
Somatics
16%
The Cancer Genome Atlas
16%
Transitional Cell Carcinoma
16%
Squamous Cell Carcinoma
15%
Leukemia
14%
Pancreas Islet Cell Tumor
13%
Long Untranslated RNA
13%
Gene Expression
13%
Immunity
12%
Gene Mutation
11%
RNA Sequencing
11%
Sarcomatoid
11%
Tamsulosin
11%
Acute Myelogenous Leukemia
10%
Wart Virus
10%
Immune Checkpoint Inhibitor
10%
Diseases
9%
Cell Plasticity
9%
Tumor Suppressor Protein
9%
Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide Like
9%
Muscle Invasive Bladder Cancer
9%
Homeostasis
9%
Acute Lymphocytic Leukemia
9%
Ontogeny
9%
Drive
9%
NPM1
9%
Nonalcoholic Fatty Liver
9%
Pediatrics
8%
Hepatocellular Carcinoma
8%
Medicine
8%
Allele
8%
Immunotherapy
8%
Tumor Microenvironment
8%
Primary Tumor
7%
Transcriptomics
7%
DNA Methylation
7%
Transcriptome
7%
Bladder Cancer
6%
Tissue Regeneration
6%
Immune Response
6%
Cancer Cell
6%
Methionine
6%
